ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
766 Views
New Horizon Health IPO Trading Update: A Blockbuster IPO but It’s Time You Plan an Exit Strategy
New Horizon Health (NHH), the pioneer in China’s colorectal cancer screening market started trading on the Hong Stock Exchange on 18th February. T
490 Views
New Horizon Health IPO: Trading Debut
New Horizon opened 1.2x higher at HK$58.40 in the grey market and last stood at HK$79. Our DCF sensitivity analysis shows that the grey market...
440 Views
New Horizon Health (诺辉健康) IPO Trading: Supply-Demand Imbalance
The sentiment is strong for both retail books and institutional book. There are strong demands from the institution side and the supply is scarce....
383 Views
SciClone Pharmaceutical IPO: Future Prospects for Zadaxin Troubling
SciClone Pharmaceuticals, a biopharmaceutical company with an integrated platform for product development and commercialisation has filed for an...
401 Views